McKesson Corporation (MCK)
Gross profit margin
Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|
Gross profit | US$ in thousands | 12,828,000 | 12,358,000 | 13,130,000 | 12,148,000 | 12,023,000 |
Revenue | US$ in thousands | 308,734,000 | 276,496,000 | 263,638,000 | 238,047,000 | 230,835,000 |
Gross profit margin | 4.16% | 4.47% | 4.98% | 5.10% | 5.21% |
March 31, 2024 calculation
Gross profit margin = Gross profit ÷ Revenue
= $12,828,000K ÷ $308,734,000K
= 4.16%
The gross profit margin of McKesson Corporation has shown a declining trend over the past five years, decreasing from 5.21% in March 2020 to 4.16% in March 2024. This indicates that the company's ability to generate profitable sales revenue has weakened over this period. The downward trajectory suggests potential challenges in managing production costs, pricing strategies, or a decrease in the efficiency of the company's operations. Further investigation into the reasons behind this decline would be necessary to identify areas for improvement in order to enhance profitability.
Peer comparison
Mar 31, 2024
Company name
Symbol
Gross profit margin
McKesson Corporation
MCK
4.16%
Cardinal Health Inc
CAH
3.27%
Cencora Inc.
COR
3.42%
Nu Skin Enterprises Inc
NUS
69.90%